Elevance Health (ELV)

Purchases of Investments

-$8.84B

TTM · Period ending: · USD

ELV logo

ELV Purchases of Investments

Latest reported-$8.84B
ELV TTM Purchases of Investments (-$5.06B → -$8.84B)
High-resolution chart · PNG

ELV purchases of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Elevance Health Purchases of Investments — Trailing twelve months (TTM) (USD)
Period endingPurchases of Investments (USD)
-8,836,000,000
-6,924,000,000
-15,797,000,000
-15,026,000,000
-15,545,000,000
-16,053,000,000
-15,847,000,000
-17,986,000,000
-6,605,000,000
-8,623,000,000
-14,896,000,000
-16,236,000,000
-29,671,000,000
-29,341,000,000
-27,339,000,000
-24,946,000,000
-23,151,000,000
-20,701,000,000
-16,741,000,000
-18,669,000,000
-17,914,000,000
-19,578,000,000
-22,574,000,000
-19,492,000,000
-22,352,000,000
-22,976,000,000
-20,781,000,000
-22,954,000,000
-19,055,000,000
-14,993,600,000
-12,866,000,000
-9,671,000,000
-13,296,100,000
-13,857,700,000
-14,777,900,000
-16,374,700,000
-13,934,600,000
-13,606,300,000
-12,391,200,000
-12,101,600,000
-11,439,600,000
-11,585,200,000
-11,672,000,000
-11,895,700,000
-12,190,900,000
-11,931,200,000
-11,808,400,000
-10,798,500,000
-10,845,000,000
-13,729,900,000
-14,088,300,000
-14,886,100,000
-15,705,500,000
-15,212,100,000
-16,442,000,000
-15,636,700,000
-14,309,800,000
-13,432,300,000
-12,732,800,000
-12,478,300,000
-12,913,200,000
-12,771,300,000
-12,434,200,000
-11,009,500,000
-10,464,100,000
-8,041,300,000
-7,161,900,000
-7,554,700,000
-6,481,000,000
-6,472,400,000
-6,777,000,000
-7,163,700,000
-7,867,800,000
-8,738,100,000
-9,596,000,000
-9,901,200,000
-10,465,300,000
-10,327,900,000
-10,791,400,000
-13,632,500,000
-19,759,900,000
-21,188,700,000
-24,890,200,000
-21,987,600,000
-16,053,200,000
-14,497,400,000
-6,270,500,000
-7,249,300,000
-6,367,500,000
-5,587,200,000
-7,479,500,000
-5,120,700,000
-5,145,700,000
-6,215,700,000
-5,585,100,000
-5,059,800,000
-4,580,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.